Use of vasoactive intestinal peptide (vip) for modulating the development of a specific immune response

• 1. 血管活性肠肽(VIP)用于治疗药源性肺炎的用途 [P] . 中国专利： CN114144195A . 2022-03-04
• 2. 血管活性肠肽(VIP)拮抗剂的组合物和用途 [P] . 中国专利： CN113795269A . 2021-12-14
• 3. NEW USE OF THE VASOACTIVE INTESTINAL PEPTIDE (VIP), ITS AGONISTS AND ANTAGONISTS TO MODULATE THE DEVELOPMENT / INITIATION OF A SPECIFIC IMMUNE RESPONSE [P] . 法国专利： FR2796280B1 . 2001-10-26

  机译： 血管肠肽（VIP），其激动剂和拮抗剂的新用途，用于调节特定免疫反应的发生/启动。

• 4. NEW USE OF THE VASOACTIVE INTESTINAL PEPTIDE (VIP), ITS AGONISTS AND ANTAGONISTS TO MODULATE THE DEVELOPMENT / INITIATION OF A SPECIFIC IMMUNE RESPONSE [P] . 法国专利： FR2796280A1 . 2001-01-19

  机译： 血管肠肽（VIP），其激动剂和拮抗剂的新用途，用于调节特定免疫反应的发生/启动。

• 5. USE OF VASOACTIVE INTESTINAL PEPTIDE (VIP) FOR MODULATING THE DEVELOPMENT OF A SPECIFIC IMMUNE RESPONSE [P] . 世界知识产权组织专利： WO0105423A1 . 2001-01-25

  机译： 使用血管肠肽（VIP）调节特定免疫反应的发生

• 1. PSMA mimotope isolated from phage displayed peptide library can induce PSMA specific immune response [J] . ZHUZHONGYU, CUIPINGZHONG, 等 细胞研究：英文版 . 1999,第004期
• 2. Effects of dietary Clostridium butyricum supplementation on growth performance,intestinal development, and immune response of weaned piglets challenged with lipopolysaccharide [J] . Ling Chen, Shengyu Xu, Bin Feng, 畜牧与生物技术杂志(英文版) . 2018,第004期
• 3. Inhalable powder formulation of vasoactive intestinal peptide derivatives , R~(15,20,21), L~(17)-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats [C] . Yosuke Aoki, Shingen Misaka, Takahiro Mizumoto Japanese peptide symposium . 2011
• 4. Specific Amino Acid Substitutions Improve the Activity and Specificity of an Antimicrobial Peptide & Serodiagnosis by Immunosignature: a Multiplexing Tool for Monitoring the Humoral Immune Response to Dengue. [D] . Wang, Xiao. 2013
• 5. Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease [O] . S G R Smalley, P A Barrow, N Foster 2009
• 6. Vasoactive intestinal peptide (VIP) differentially affects inflammatory immune responses in human monocytes infected with viable Salmonella or stimulated with LPS [O] . Askar, Basim Ali, Ibrahim, Hiba, Barrow, Paul, 2015

• 1. Vasoactive Intestinal Peptide (VIP) and VIP Receptors-Elucidation of Structure and Function for Therapeutic Applications [J] . Hisato Igarashi ,Nao Fujimori ,Tetsuhide Ito . 临床医学国际期刊（英文） . 2011,第4期
• 2. Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings [J] . Ritchie C. Shoemaker ,Dennis House ,James C. Ryan . 健康（英文） . 2013,第3期
• 3. Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses [J] . Xian-Hua Wang ,Yan Qin ,Mei-Hao Hu . 世界胃肠病学杂志：英文版 . 2005,第36期
• 4. 甲状腺激素对大鼠脑胆囊收缩素(CCK)及血管活性肠肽(VIP)基因表达的调节 [C] . 宋学文 . 第八次全国生物化学与分子生物学学术会议 . 1997
• 5. 血管活性肠肽(VIP)对CIA大鼠的免疫调节涉及NF-κB表达和活性 [A] . 祝瑾 . 2009